Safety of a nasal spray in healthy adults
Part of Infections clinical trials.
This trial tests a new nasal spray (called LMN-1001) in healthy adults to see if it is safe and how the body handles it. It is an early-phase study, so the main goal is not to treat a disease but to check for safety and side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 64 years old.
- You must be in good general health, without significant long-term illnesses (like heart, lung, kidney, or immune system conditions).
- You must not have allergies, asthma, or current nose or sinus problems that could affect the treatment.
- You must not use nasal sprays, nasal drops, or inhaled medications regularly.
- You must be willing to come for follow-up visits for up to 28 days after receiving the study drug.
- If you can have children, you must agree to use effective birth control during the study and for a period after (30 days for women, 90 days for men).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new nasal spray (DMI019) in healthy volunteers to see if it is safe and how the body handles it. Participants will receive a single dose and be monitored for a few weeks.
This study tests a new nasal spray COVID-19 vaccine to see how it compares to an mRNA booster shot. It is for healthy adults who have already had at least 3 doses of an mRNA COVID-19 vaccine (or 2 doses plus a confirmed COVID infection) and are looking for a needle-free booster option.
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
This trial tests a nasal spray, INNA-051, that may help your nose and airways fight off viruses that cause respiratory infections like colds and flu. It is for healthy adults aged 18-45 who are around many people and may be exposed to germs.
This trial tests the safety and how the body processes a new throat spray called Grammidin. Healthy volunteers will use the spray so researchers can see how it works and if there are any side effects.
This trial tests a new throat spray called Grammidin With Anesthetic to see if it is safe and how the body processes it. Healthy volunteers take the spray and are monitored for side effects and drug levels in the blood.
Hear when a new Viral Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.